Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts.
Sports Health. 2009 Mar;1(2):137-44. doi: 10.1177/1941738108331197.
The objective of this study is to assess the effectiveness of extracorporeal shock wave therapy in the management of calcifying tendinitis of the shoulder. Furthermore, a dose-response relationship was sought as a secondary confirmation of effectiveness.
Focused extracorporeal shock wave therapy has a high, dose-responsive effectiveness in the management of calcifying tendinitis of the shoulder.
Meta-analysis.
Studies were identified from online databases (MEDLINE, EMBASE, and Cochrane Controlled Trials Register), manual searches, and personal communication with experts in the field. After assessment of heterogeneity, a random effects model was generated. The primary end points were identified as pain and function by using the visual analog scale and the Constant-Murley Score, respectively. These end points were pooled and the weighted mean differences and 95% confidence intervals were estimated. Odds ratios of the secondary end point deposit resorption were pooled.
In 14 studies, shock wave therapy led to a significantly higher reduction of pain (weighted mean difference, -2.8 points; 95% confidence interval, -4.2 to -1.5 points) and improvement of function (weighted mean difference, 19.8 points; 95% confidence interval, 13.4-26.3 points), compared to other treatments and placebo. High-energy treatment produced significantly better results than low-energy treatment for pain reduction (weighted mean difference, 1.7 points; 95% confidence interval, 0.7-2.6 points) and improvement of function (weighted mean difference, 10.7 points; 95% confidence interval, 7.2-14.1 points). These results are consistent with a dose-response relationship supporting the effectiveness of shock wave therapy.
Shock wave therapy for calcifying tendinitis of the shoulder is effective in pain relief, function restoration, and deposit resorption; however, these conclusions are susceptible to bias arising from the limitations of the included studies.
本研究旨在评估体外冲击波疗法在治疗肩钙化性肌腱炎中的疗效。此外,还寻求了剂量-反应关系作为疗效的次要确认。
聚焦式体外冲击波疗法在治疗肩钙化性肌腱炎方面具有较高的、剂量反应性的疗效。
荟萃分析。
从在线数据库(MEDLINE、EMBASE 和 Cochrane 对照试验登记处)、手动搜索和与该领域专家的个人交流中确定研究。在评估异质性后,生成随机效应模型。主要终点分别为疼痛和功能,采用视觉模拟评分和 Constant-Murley 评分。汇总这些终点,估计加权均数差和 95%置信区间。次要终点沉积吸收的优势比也进行了汇总。
在 14 项研究中,与其他治疗方法和安慰剂相比,冲击波疗法可显著降低疼痛(加权均数差,-2.8 分;95%置信区间,-4.2 至-1.5 分)和改善功能(加权均数差,19.8 分;95%置信区间,13.4-26.3 分)。高能治疗在减轻疼痛(加权均数差,1.7 分;95%置信区间,0.7-2.6 分)和改善功能(加权均数差,10.7 分;95%置信区间,7.2-14.1 分)方面的效果明显优于低能治疗。这些结果与支持冲击波疗法有效性的剂量-反应关系一致。
体外冲击波疗法治疗肩钙化性肌腱炎在缓解疼痛、恢复功能和沉积吸收方面有效;然而,这些结论容易受到纳入研究的局限性所带来的偏倚的影响。